ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.306,33
0,17%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Karyopharm Therapeutics Inc (KPTI)

  7. Karyopharm Therapeutics Inc (KPTI) News

KPTI Karyopharm Therapeutics Inc

0,945
-0,075 (-7,35%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Karyopharm Therapeutics Inc KPTI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,075 -7,35% 0,945 06:00:14
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,9951 0,9444 1,01 0,9565 1,02
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.6.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06.6.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.6.202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
01.6.202419:45PRNUSKaryopharm Presents Updated Exploratory Subgroup Analyses..
31.5.202414:00EDGAR2Form 8-K - Current report
30.5.202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.5.202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.5.202422:44EDGAR2Form S-3 - Registration statement under Securities Act of..
30.5.202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.5.202422:05PRNUSKaryopharm to Participate at the Jefferies Global Healthcare..
23.5.202422:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.5.202422:06EDGAR2Form 8-K - Current report
08.5.202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:05PRNUSKaryopharm to Participate at the 2024 RBC Capital Markets..
08.5.202413:52EDGAR2Form 8-K - Current report
08.5.202413:47EDGAR2Form 8-K - Current report
08.5.202413:30PRNUSKaryopharm Reports First Quarter 2024 Financial Results and..
07.5.202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.5.202422:30PRNUSKaryopharm to Report First Quarter 2024 Financial Results on..
01.5.202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
24.4.202422:01PRNUSKaryopharm Announces Presentations in Endometrial Cancer and..
01.4.202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
06.3.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:05PRNUSKaryopharm to Participate at Barclays 26th Annual Global..
05.3.202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
29.2.202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202413:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202413:35EDGAR2Form 8-K - Current report
29.2.202413:30PRNUSKaryopharm Reports Fourth Quarter and Full Year 2023..
22.2.202413:00PRNUSKaryopharm to Report Fourth Quarter and Full Year 2023..
20.2.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202414:00EDGAR2Form 8-K - Current report
14.2.202416:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
26.1.202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
KPTI
Karyopharm Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten